The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
University of Arizona
Kidney Cancer Research Bureau
Second Life Therapeutics
National Institutes of Health Clinical Center (CC)
BicycleTx Limited
ITM Oncologics GmbH
Maastricht University Medical Center
Palleon Pharmaceuticals, Inc.
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
PureTech
UNICANCER
SCG Cell Therapy Pte. Ltd.
GeneMedicine Co., Ltd.
Klus Pharma Inc.
Kineta Inc.
Incyte Corporation
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Duke University